Compare UBXG & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UBXG | RMTI |
|---|---|---|
| Founded | 2018 | 1994 |
| Country | China | United States |
| Employees | N/A | 300 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8M | 32.9M |
| IPO Year | 2021 | 2022 |
| Metric | UBXG | RMTI |
|---|---|---|
| Price | $3.09 | $0.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | ★ 8.3M | 262.8K |
| Earning Date | 06-18-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,258,000.00 |
| Revenue This Year | N/A | $8.64 |
| Revenue Next Year | N/A | $8.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.11 | $0.74 |
| 52 Week High | $4.49 | $2.10 |
| Indicator | UBXG | RMTI |
|---|---|---|
| Relative Strength Index (RSI) | 77.95 | 34.87 |
| Support Level | $2.64 | N/A |
| Resistance Level | $3.60 | $1.00 |
| Average True Range (ATR) | 0.15 | 0.04 |
| MACD | 0.39 | -0.00 |
| Stochastic Oscillator | 89.05 | 15.84 |
U-BX Technology Ltd focuses on providing value-added services using artificial intelligence-driven technology to businesses in the insurance industry, including insurance carriers and brokers. Its main offerings include three services/products: digital promotion services, risk assessment services, and value-added bundled benefits. The PRC operating entities help their institutional clients gain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or clients' promotion time on these channels. U-BX Beijing developed a unique algorithm named the Magic Mirror. The majority of revenue comes from digital promotion services. Geographically, all of the company's revenue is derived from Mainland China.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.